A clinician explains how sparsentan is changing treatment strategies for patients with FSGS.
George Vasquez-Rios, MD
Advertisement
George Vasquez-Rios, MD, MSCR, FASN, is a nephrologist and glomerular disease specialist and director of the Glomerular & Genetic Diseases Center.
Articles by George Vasquez-Rios, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
FDA Approves Enlicitide for LDL-C Lowering in Adults With Hypercholesterolemia
2
What New 26-Week COMP006 Data Mean for TRD, With Boadie Dunlop, MD
3
Daily Inhaled TPIP Improved PAH Measures at 12 Months in OLE
4
FIND-CKD Trial Poses Finerenone as a "Third Pillar" for Nondiabetic CKD
5